
Business & Assets of UK-Based Healthcare Company
BPI Asset Advisory is urgently seeking expressions of interest in the Business and Assets of this company.
BPI Asset Advisory is urgently seeking expressions of interest in the Business and Assets of this company.
Information
An opportunity to purchase the intangible and tangible assets of a healthcare company with clinical trial data, established drug-free products supported by an experienced management team.
Intangible Assets
• Customer Database: 12 Principal Customers comprising High Street Stores, BlueChip Healthcare and Online Distributors across UK and Ireland, 4 Third Party Distributors in Europe, Asia and Middle East
• Debtors: £412,075.11
• 14 Trademarks (GB and International)
• Licences
• CE mark
• Clinical Trial Data
• Premises: Serviced Office Accommodation, London
• Employees: 7
Tangible Assets
Stock
• Product 1: Drug-free topical gel for treating joint pain (Class 3 Medical Device UK and EU registered) – Previously delivered sales of circa £2.8m annually
• Product 2: Non Drug range of Clinically Trialled Cosmetic Preparation for treating several dermatoses – Currently Not Marketed
• Product 3: Equine Joint Care Product – Targeted at US Market, however currently withdrawn
• 5 variants of Product 1, comprising 148,700 Units at a cost value of £273,262 – (Note. Stock held at third party warehousing and logistics provider located in the Midlands)
Assets
• Associated IT Systems, office furniture, telecoms equipment.
Offer Deadline: Friday 29 August 2025 4:00 pm
Interested Parties
For further information, and to receive an NDA please email info@bpiaa.com
Sell your business assets with our
hassle-free selling process
Register to bid on
1000’s of auctions
Save thousands
over RRP
Keep up to date with
the latest auctions